Skip to content

The effect of valsalva maneuver and distraction on pain intensity during vascular needle insertion in hemodialysis patients

The effect of valsalva maneuver and distraction on pain intensity during vascular needle insertion in hemodialysis patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151228025732N81
Enrollment
30
Registered
2024-01-17
Start date
2024-01-20
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain intensity. Pain, not elsewhere classified

Interventions

Intervention 1: Intervention group: In this group (Valsalva maneuver), according to the protocol, the patient blew into a disposable plastic tube connected to a mercury sphygmomanometer (Easy Life, TX

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 and above Minimum literacy to recognize numbers Performing hemodialysis through an arteriovenous fistula At least three months have passed since the start of hemodialysis through the fistula Absence of simultaneous pain in other parts of the body Not receiving drugs and painkillers from 6 hours ago

Exclusion criteria

Exclusion criteria: Injury or lesion in the hand with fistula Patients who are unable to perform the Valsalva maneuver by keeping the mercury column higher than 20 mmHg for 20 seconds. Failure to take a vein from the person in the first attempt The presence of phlebitis at the site of the fistula Patients with a history of cardiovascular disease (bradycardia, hypotension, and CHB) and cerebrovascular disease

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: One minute after inserting the arterial needle and fixing it. Method of measurement: Numeric Pain Rating Scale (NRPS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Asgari

Semnan University of Medical Sciences

are20935@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026